FR2575655B1 - Utilisation d'un interferon a faibles doses notamment pour regler l'appetit et l'efficacite de l'utilisation des aliments - Google Patents

Utilisation d'un interferon a faibles doses notamment pour regler l'appetit et l'efficacite de l'utilisation des aliments

Info

Publication number
FR2575655B1
FR2575655B1 FR868600046A FR8600046A FR2575655B1 FR 2575655 B1 FR2575655 B1 FR 2575655B1 FR 868600046 A FR868600046 A FR 868600046A FR 8600046 A FR8600046 A FR 8600046A FR 2575655 B1 FR2575655 B1 FR 2575655B1
Authority
FR
France
Prior art keywords
appetite
food
adjusting
efficiency
low
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR868600046A
Other languages
English (en)
Other versions
FR2575655A1 (fr
Inventor
Joseph M Cummins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Texas A&M University System
Original Assignee
Texas A&M University System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas A&M University System filed Critical Texas A&M University System
Publication of FR2575655A1 publication Critical patent/FR2575655A1/fr
Application granted granted Critical
Publication of FR2575655B1 publication Critical patent/FR2575655B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR868600046A 1985-01-04 1986-01-03 Utilisation d'un interferon a faibles doses notamment pour regler l'appetit et l'efficacite de l'utilisation des aliments Expired - Lifetime FR2575655B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/688,868 US4820515A (en) 1982-12-13 1985-01-04 Method of using interferon in low dosage to regulate appetite and efficiency of food utilization

Publications (2)

Publication Number Publication Date
FR2575655A1 FR2575655A1 (fr) 1986-07-11
FR2575655B1 true FR2575655B1 (fr) 1991-03-29

Family

ID=24766112

Family Applications (1)

Application Number Title Priority Date Filing Date
FR868600046A Expired - Lifetime FR2575655B1 (fr) 1985-01-04 1986-01-03 Utilisation d'un interferon a faibles doses notamment pour regler l'appetit et l'efficacite de l'utilisation des aliments

Country Status (8)

Country Link
US (1) US4820515A (fr)
AU (1) AU583332B2 (fr)
BR (1) BR8600071A (fr)
DE (1) DE3600083C2 (fr)
FR (1) FR2575655B1 (fr)
IT (1) IT1207573B (fr)
NZ (1) NZ214702A (fr)
ZA (1) ZA859894B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910304A (en) * 1982-12-13 1999-06-08 Texas A&M University System Low-dose oral administration of interferons
DE3434345A1 (de) * 1984-09-19 1986-03-27 Hoechst Ag, 6230 Frankfurt Verwendung von (alpha)-interferonen zur bekaempfung von durchfaellen
US4820514A (en) * 1985-12-30 1989-04-11 Texas A&M University System Low dosage of interferon to enhance vaccine efficiency
CA1320905C (fr) * 1986-11-06 1993-08-03 Joseph M. Cummins Traitement d'affections immuno-resistantes
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
EP0619120B1 (fr) * 1993-04-09 2002-09-11 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Utilisation de l'interféron-d humain pour la fabrication d'un médicament pour le traitement de maladies respiratoires des chats
US5885567A (en) * 1993-10-22 1999-03-23 University Of Connecticut Treatment of infection in fowl by oral administration of avian interferon proteins
AUPN976596A0 (en) * 1996-05-09 1996-05-30 Pharma Pacific Pty Ltd Stimulation of host defence mechanisms
WO2001041782A2 (fr) * 1999-12-09 2001-06-14 Chiron Corporation Procede d'administration de cytokine aux systeme nerveux central et systeme lymphatique
DE60332358D1 (de) 2002-09-09 2010-06-10 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
US20080260820A1 (en) * 2007-04-19 2008-10-23 Gilles Borrelly Oral dosage formulations of protease-resistant polypeptides
US9642893B2 (en) 2013-07-03 2017-05-09 Joseph Cummins Method for reducing injury and stabilizing muscle using orally administered interferon

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906092A (en) * 1971-11-26 1975-09-16 Merck & Co Inc Stimulation of antibody response
US4132775A (en) * 1973-12-03 1979-01-02 Richardson-Merrell Inc. Infectious bovine rhinotracheitis virus vaccine and method of preparing and using the same
ZA754725B (en) * 1974-08-01 1976-06-30 H Stickl Preparation for the treatment of infectious diseases, method for the manufacture thereof, and its use
DK485977A (da) * 1977-11-01 1979-05-02 Ess Foodeksport Fremgangsmaade til udvinding af et biologisk aktivt materiale fra svineblodfraktioner
GB2016015B (en) * 1978-01-22 1982-05-06 Hayashibara Co Method of preparing interferon and preparations containing interferon
IN150740B (fr) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4460574A (en) * 1980-06-16 1984-07-17 Yabrov Alexander A Prophylaxis or treatment of interferon-sensitive diseases
WO1982000588A1 (fr) * 1980-08-22 1982-03-04 Illinois Univ Administration de composants biologiquement actifs d'isolats d'interferons d'especes heterologues
US4462985A (en) * 1980-08-22 1984-07-31 University Of Illinois Foundation Delivery of biologically active components of heterologous species interferon isolates
EP0080879B1 (fr) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Composition pharmaceutique contenant de l'interféron stabilisé
EP0107498B1 (fr) * 1982-10-25 1990-05-16 Genentech, Inc. Activité synergétique d'interféron humain
US4497795A (en) * 1982-12-13 1985-02-05 The Texas A&M University System Method of regulating appetite and efficiency of food utilization employing interferon
EP0177342A3 (fr) * 1984-10-04 1987-12-02 Genentech, Inc. Formulations orales de protéines thérapeutiques
AU5234586A (en) * 1984-12-06 1986-07-01 Tyrrell, D.A.J. Improvements relating to the treatment control and preventionof rhinovirus infections

Also Published As

Publication number Publication date
AU5163085A (en) 1986-07-10
NZ214702A (en) 1989-04-26
IT8619011A0 (it) 1986-01-03
FR2575655A1 (fr) 1986-07-11
DE3600083A1 (de) 1986-09-18
US4820515A (en) 1989-04-11
ZA859894B (en) 1986-12-30
DE3600083C2 (de) 1996-07-25
AU583332B2 (en) 1989-04-27
IT1207573B (it) 1989-05-25
BR8600071A (pt) 1986-09-23

Similar Documents

Publication Publication Date Title
DE3662142D1 (en) Novel fluorovinyl ether and copolymer comprising the same
GB2180837B (en) Photoresist compositions and polymers therefor
EG18024A (en) Vetement unique notamment pour enfants comportant des moyens evitant l'enfilage
EP0224593A4 (fr) Orifice de versement d'un emballage.
NZ218089A (en) 7-piperazinyl, 4-oxoquinolines and pharmaceutical compositions
GB8608149D0 (en) Furazolidine dosage form
GB8615043D0 (en) Solid stable dosage forms
GB8619877D0 (en) Casting food product
FR2575655B1 (fr) Utilisation d'un interferon a faibles doses notamment pour regler l'appetit et l'efficacite de l'utilisation des aliments
NZ214821A (en) Spiro-dioxolanes, -dithiolanes and -oxothiolanes and pharmaceutical compositions
EP0206460A3 (en) L-phenylalanine dehydrogenase and use thereof
NZ215753A (en) Phenethanolamine derivatives and pharmaceutical compositions
BG41897A1 (en) Dichlormethylate of n, n'- 4, 10- dioxa- 3, 11- bis- tetrahydropapaverine and method for its preparation
NZ215070A (en) Imidazole-indoles and pharmaceutical compositions
NZ216438A (en) Steroid-pyrazoles and pharmaceutical compositions
IL80434A0 (en) 5-aryl-2,4-dialkyl-3h-1,2,4-triazole-3-thiones and antidepressant pharmaceutical compositions
GB8609791D0 (en) Dental cream
NZ219719A (en) Endo-4-amino-5-chloro-2-methoxy-n-cl-azabicyclo -(3,3,1)-non-4-yl)-benzamide and pharmaceutical compositions
NZ217248A (en) Gem-dihalo-1,8-diamino-4-aza-octones and pharmaceutical compositions
GB8629654D0 (en) Dental cream package
GR862225B (en) Pachaged dental cream
IL80733A0 (en) 2,2'-bi-1h-imidazoles and pharmaceutical compositions containing same
NZ218085A (en) 5-heterocyclic-2,4-dialkyl-3h-1,2,4-triazole-3-thiones and pharmaceutical compositions
NZ208337A (en) 2-(2-hydroxy-3-((2-(ar-hydroxy-1h-aminopropoxy-yl)ethyl benzonitriles and pharmaceutical compositions
GB8523046D0 (en) Condiment dispenser

Legal Events

Date Code Title Description
CL Concession to grant licences
ST Notification of lapse